What is Quest Diagnostics's SG&A?

Quest Diagnostics (DGX) reported SG&A of $529M in Q2 2026.

How has Quest Diagnostics's SG&A changed year-over-year?

Quest Diagnostics's SG&A increased by 8.8% year-over-year, from $486M to $529M.

What is the long-term trend for Quest Diagnostics's SG&A?

Over 4 years (2021 to 2025), Quest Diagnostics's SG&A has grown at a 3.3% compound annual growth rate (CAGR), from $1.73B to $1.97B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Quest Diagnostics DGX SG&A

SG&A at other companies

Labcorp HoldingsLH

$577.2M-0.4%

Opko HealthOPK

$52.92M-11.2%

Exagen Inc.XGN

$12.07M+7.7%

Personalis, Inc.PSNL

$17.9M+46.0%

Natera, Inc.NTRA

$327.94M+22.9%

Agilent TechnologiesA

$465M+2.4%

Other financials

Income statement

See full

Revenue$3.0B+10.2%

Gross profit$1.0B+8.9%

Operating income$459.0M+4.8%

Net income$320.0M+13.5%

EPS (diluted)$2.84+15.0%

Balance sheet

See full

Cash & equivalents$626.0M+96.2%

Total debt$6.4B0.0%

Total equity$7.5B+4.0%

Total assets$16.9B+6.1%

Cash flow

See full

Operating cash flow$597.0M+9.7%

CapEx$138.0M+27.8%

Free cash flow$459.0M+5.3%

Valuation

See full

Market cap$26.04B+38.7%

Enterprise value$31.8B+28.0%

P/E24.5×+4.8×

P/S2.3×+0.5×

Profitability

See full

Gross margin33.1%+0.1pp

Operating margin14.1%+0.1pp

Net margin9.2%+0.2pp

FCF margin11.7%0.0pp

Returns & leverage

See full

Return on equity14.4%+0.7pp

Debt / equity0.8×0.0×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Quest Diagnostics’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quest Diagnostics's SG&A?: Quest Diagnostics (DGX) reported SG&A of $529M in Q2 2026.
How has Quest Diagnostics's SG&A changed year-over-year?: Quest Diagnostics's SG&A increased by 8.8% year-over-year, from $486M to $529M.
What is the long-term trend for Quest Diagnostics's SG&A?: Over 4 years (2021 to 2025), Quest Diagnostics's SG&A has grown at a 3.3% compound annual growth rate (CAGR), from $1.73B to $1.97B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.